The HLA typing for the transplants market is projected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. North America accounted for the largest share of the HLA typing for the transplants market, followed by Europe.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
The demand for transplant diagnostic products for HLA typing is expected to grow mainly due to factors such as technological advancements, the growing number of diagnostic centers & hospitals, increased applications in patient profiling, and rising public-private investments to support product development.
Market Segmentation
Based on the product, the reagents & consumables segment held the largest share of the market
Based on the product, the HLA typing for the transplants market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global HLA typing for the transplants market
Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.
Based on technology, the HLA typing for the transplants market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period.
Based on the application, the diagnostic application segment accounted for the largest share of this market
Based on the application, the HLA typing for the transplants market is categorized into diagnostic and research applications. Diagnostic applications accounted for the largest share of the HLA typing for the transplants market
North America accounted for the largest share of the HLA typing for transplants market
North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742
Key Market Players
Some of the players in the HLA typing for transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), Immucor, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary)
Report Objectives
- To define, describe, and forecast the HLA typing for transplants market based on product, technology, application, transplant type, end-user, and region
- To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micro markets with respect to individual growth trends, prospects, and their contributions to the overall HLA typing for transplants market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the market value of various segments and subsegments for five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the HLA typing for transplants market and comprehensively analyze their global revenue shares and core competencies
- To track and analyze competitive market-specific developments such as product launches/approvals and enhancements; partnerships, collaborations, agreements; expansions; and acquisitions
Get Free Customization @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian